The company raised its full-year profit forecast as it expected higher demand for vaccines, plasma and recombinant products amid the COVID-19 pandemic.said on Tuesday it was pausing clinical trials of a COVID-19 vaccine candidate due to an unexplained illness in a participant.also said it would halt its coronavirus antibody trial on safety concerns.
Diminishing hopes for the passage of a U.S. coronavirus bill also added to the gloom after House Speaker Nancy Pelosi rejected the $1.8 trillion coronavirus relief proposal from the White House, calling it inadequate to support the pandemic-ravaged economy.led losses, falling 1.1%. The"Big Four" lenders slid between 1% and 1.5%.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: